Bionostra is engaged in the R&D and commercialization of biotechnology services.
Bionostra has raised €2.0M across 1 funding round from 1 investor, most recently a Series B round in Oct 2005. Based in Tres Cantos, Spain. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2005-10-01 | Series B |
| €2.0M |
| Clave Mayor |
| View deal → |
